Breakthrough, de novo, or PMA? FDA Submission Pathways for Novel Devices

Published: Aug. 9, 2022, 1:24 p.m.

You've developed a novel technology and want to bring it to market in the US. Now what? Can you submit as a breakthrough device, or is the de novo route a better choice? How are they different? How are they similar? \n\nBreathe - and listen in as Michelle walks you through the options.